[Hormones and mammographic breast density]
- PMID: 18772804
- DOI: 10.1016/s0221-0363(08)73930-1
[Hormones and mammographic breast density]
Abstract
Breast constitutional density may be altered and increased (acquired density) by hormonal interventions such as hormone replacement therapy (HRT). The effects of endogenous (steroids, prolactin, insulin-like factors...) and exogenous (HRT, levonorgestrel IUD, tibolone, tamoxifen, SERMs) hormones will be reviewed. Continuous combined estrogen-progestin preparations are most likely to cause an increase in density. Estrogen alone and tibolone are less likely to cause an increase in density. The sensitivity and specificity of mammography are decreased, with increased risk of interval carcinoma and rate of short interval follow-up from false positive results. The issue with regards to interruption of the hormonal therapy prior to mammography, and the duration of the interruption, are discussed.
Similar articles
-
Biological significance of interventions that change breast density.J Natl Cancer Inst. 2003 Jan 1;95(1):4-5. doi: 10.1093/jnci/95.1.4. J Natl Cancer Inst. 2003. PMID: 12509389 No abstract available.
-
The need for tissue selective menopausal agents.Gynecol Endocrinol. 2005 Jul;21 Suppl 1:22-7. doi: 10.1080/09513590400030020. Gynecol Endocrinol. 2005. PMID: 16112952 Review.
-
Effects of hormone replacement therapy on mammographic findings.Arch Gynecol Obstet. 2003 Apr;268(1):5-8. doi: 10.1007/s00404-002-0306-7. Epub 2002 Jun 6. Arch Gynecol Obstet. 2003. PMID: 12673467
-
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.Gynecol Endocrinol. 2005 Feb;20(2):110-5. doi: 10.1080/09513590400021151. Gynecol Endocrinol. 2005. PMID: 15823831 Clinical Trial.
-
[Menopausal hormonal therapies: impact on mammographic breast density].J Radiol. 2004 Oct;85(10 Pt 1):1673-86. doi: 10.1016/s0221-0363(04)97731-1. J Radiol. 2004. PMID: 15669560 Review. French.
Cited by
-
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2. Cochrane Database Syst Rev. 2021. PMID: 34697802 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical